Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Biogen
This is a cross-sectional, multi-center, multi-national, epidemiological study to estimate the prevalence of anti-JCV antibody in MS participants. This study will provide an estimate of the prevalence of anti-JCV antibody in the MS population and will investigate inter-country differences.
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
All candidates for this study must have the ability to understand the purpose of the study and provide signed and dated informed consent.
All patients with a diagnosis of Multiple Sclerosis (MS) of any type, irrespective of their treatment, are eligible to participate once.
